Literature DB >> 3132952

HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms.

A B Sönnerborg1, A C Ehrnst, S K Bergdahl, P O Pehrson, B R Sköldenberg, O O Strannegård.   

Abstract

Human immunodeficiency virus (HIV) could be isolated from the cerebrospinal fluid (CSF) of the majority (62%) of 72 patients in various stages of HIV infection. This high rate of successful virus isolation was achieved only when the time from lumbar puncture to initiation of the cell cultures was short, i.e. not exceeding 5 h. The HIV isolation rates were equally high in patients with persistent generalized lymphadenopathy (PGL), AIDS-related complex (ARC) and AIDS. Although the HIV recovery rate was low in patients with normal immunological parameters it was not correlated with the degree of severity of the immunodeficiency in the other patients. Furthermore, the recovery rates were not significantly correlated to the duration of the infection. HIV was recovered as often from patients with neurological symptoms as from patients without such symptoms. These findings suggest that in the majority of patients there is central nervous system (CNS) involvement early in the course of HIV infection and that HIV replication in the CNS may occur in the absence of a pronounced systemic cellular immunodeficiency and frequently without causing overt neurological symptoms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132952     DOI: 10.1097/00002030-198804000-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals.

Authors:  F Chiodi; B Keys; J Albert; L Hagberg; J Lundeberg; M Uhlén; E M Fenyö; G Norkrans
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.

Authors:  N S Ku; Y Lee; J Y Ahn; J E Song; M H Kim; S B Kim; S J Jeong; K-W Hong; E Kim; S H Han; J Y Song; H J Cheong; Y G Song; W J Kim; J M Kim; D M Smith; J Y Choi
Journal:  HIV Med       Date:  2014-02-24       Impact factor: 3.180

3.  Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

4.  Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.

Authors:  Ulf Karlsson; Liselotte Antonsson; Johanna Repits; Patrik Medstrand; Christer Owman; Karin Kidd-Ljunggren; Lars Hagberg; Bo Svennerholm; Marianne Jansson; Magnus Gisslén; Bengt Ljungberg
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

Review 5.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

Review 6.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11

7.  The neurotoxin-like sequence of human immunodeficiency virus gp120: a comparison of sequence data from patients with and without neurological symptoms.

Authors:  A Sönnerborg; B Johansson
Journal:  Virus Genes       Date:  1993-02       Impact factor: 2.332

8.  Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.

Authors:  J R Bogner; B Junge-Hülsing; U Kronawitter; I Sadri; A Matuschke; F D Goebel
Journal:  Clin Investig       Date:  1992-08

Review 9.  Controversies in HIV-associated neurocognitive disorders.

Authors:  Sam Nightingale; Alan Winston; Scott Letendre; Benedict D Michael; Justin C McArthur; Saye Khoo; Tom Solomon
Journal:  Lancet Neurol       Date:  2014-11       Impact factor: 44.182

10.  Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.

Authors:  Paulo P Christo; Dirceu B Greco; Agdemir W Aleixo; Jose A Livramento
Journal:  BMC Infect Dis       Date:  2007-12-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.